"IF, we get past 1.2c there are are not a lot of sellers currently lined up at those levels."
More importantly - there's no buyers above 0.008.
On my reading - the announcement declares CGB as a Canntab distributor that is also latching onto the CMOS study. Is that a fair summary?
I do feel for the genuine shareholders who have a belief in this company. However, it is my observation that the announcement is not too dissimilar to the many that have precede this one.
As at time of writing - comparatively low volume. SP stuck at 0.008 and that line is getting chomped up.
And what about those early predictions of 2c and above? Some posters are often accused of down ramping (whatever the hell that is) ... so what about those early posts made today? Are they ramping posts because of the 2c, 10c predictions?
- Forums
- ASX - By Stock
- CGB
- Ann: Export Permit Granted for Patented Canntab Hard Pill
Ann: Export Permit Granted for Patented Canntab Hard Pill, page-60
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CGB (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO & MD
Anthony Noble
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online